Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rivaroxaban (xarelto) (3 trials)
acetylsalicylic acid (aspirin) (1 trial)
aldesleukin (Proleukin) (1 trial)
apixaban (eliquis) (1 trial)
clopidogrel (plavix) (1 trial)
colchicine (colbenemid) (1 trial)
enoxaparin (lovenox) (1 trial)
ixekizumab (taltz) (1 trial)
COVID-19 convalescent plasma (1 trial)
oxybutynin (ditropan) (1 trial)
tetrahydrogestrinone (1 trial)
estradiol (progynon depot) (1 trial)
Ischemia (Phase 3)
Thromboembolism (Phase 3)
Thrombosis (Phase 3)
Venous Thromboembolism (Phase 3)
Trials (9 total)
Trial APIs (12 total)